Old Web
English
Sign In
Acemap
>
authorDetail
>
V. Sashi Gopaul
V. Sashi Gopaul
Johnson & Johnson Pharmaceutical Research and Development
Chemistry
Dapagliflozin
Internal medicine
Endocrinology
Isoquinoline
3
Papers
6
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
120-OR: Dapagliflozin Increases Adiponectin and Its Receptors, and Reduces Inflammation and Ceramide Synthesis Enzymes in the Obese Prediabetic Dog
2021
Diabetes
Morvarid Kabir
Richard N. Bergman
V. Sashi Gopaul
Hsiu-Chiung Yang
Cathryn M. Kolka
Show All
Source
Cite
Save
Citations (0)
1711-P: Dapagliflozin Promotes Adipose Beiging and Lipolysis and Reduces Adipocyte Size in the Obese Prediabetic Dog
2020
Diabetes
Morvarid Kabir
Richard N. Bergman
Francesca Piccinini
Darko Stefanovski
V. Sashi Gopaul
Hsiu-Chiung Yang
Cathryn M. Kolka
Show All
Source
Cite
Save
Citations (0)
In‐vitro metabolism of isotetrandrine, a bisbenzylisoquinoline alkaloid, in rat hepatic S9 fraction by high‐performance liquid chromatography‐atmospheric pressure ionization mass spectrometry
2004
Journal of Pharmacy and Pharmacology
Wu-Nan Wu
L. A. McKown
V. Sashi Gopaul
Show All
Source
Cite
Save
Citations (6)
1